News

How can women be empowered to take control of their own fertility?

Jane Tkachenko and Health Awareness online platform discussed the topic of women's health and particularly the sensitive subject of PCOS - (Polycystic Ovary Syndrome), which affects around 1 out of 10 women in the UK and is one of the most common conditions impacting women’s fertility. 

How to identify it, and what are the symptoms? - These answers you may find online or by visiting your local GP. However, knowing more about it beforehand will help to evaluate the options given by the doctor rationally.  Сlick the link below to read about what Jane Tkachenko - the director of Amaxa, comments on this topic and how Miofolic may be the starting point in this journey. 

The 2023 Neonatal/Perinatal Medical Forum (NPMF) will be held from March 9th to March 11th in Bucharest, Romania.

The congress continues the tradition of being a great academic occasion offering the latest advances in clinical care and research in Perinatology and Neonatology.

European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update

Respiratory distress syndrome (RDS) is a breathing disorder caused by immature lungs that affects preterm babies, particularly those born more than 6 weeks before their due date.

What can the pharmaceutical industry do to ensure it’s ready for a future pandemic?

The Covid-19 pandemic is challenging the opportunity of the global healthcare system, governments, and pharmacy companies.

How the pharmaceutical industry leaders are preparing for the next wave of the Covid-19 pandemic

Despite the fact that the Covid-19 pandemic is still far from being declared completed, there are some positive aspects.

International workshop in Vienna

On October 16-17, was the International workshop on the implementation of new requirements for registration of medicines on the territory of the Eurasian Economic Union (EAEC) held on.

From a short interview for Pharmaceutical Executive magazine:

In the meantime, the gap between foreign and local product prices has significantly increased during the crisis, which probably explains why domestic companies’ market share has increased from 63 to 78 percent (in volume) over the past three years.

Brexin, new product in Amaxa’s portfolio

Soon, another product, Brexin, produced by Chiesi, will be added to our Company's portfolio. This product was the focus of the 17th international workshop, which was held on May 13-15 in Tallinn (Estonia).

Amaxa has recently become the official representative of Caris Molecular Intelligence

Amaxa has recently become the official representative of Caris Molecular Intelligence, a cutting-edge technology for studying oncological tumors. In today's medical landscape, innovative technologies and diagnostic methods ...